Rodriguez M.P.
56
Coauthors
5
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Medicina veterinaria | 3 |
| Biotecnología | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Ganadería | 5 |
| Microorganismos, hongos y algas | 2 |
| Fisiología humana | 2 |
| Medicina forense; incidencia de enfermedades | 1 |
| Química y ciencias afines | 1 |
| Comidas y servicio de mesa | 1 |
| Ingeniería y operaciones afines | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 5 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Farnos O. | 5 |
| Maritza Barrera | 5 |
| Toledo J.R. | 5 |
| Sanchez O. | 5 |
| Frias M.T. | 4 |
| Montesino R. | 3 |
| Ganges L. | 2 |
| Castell S. | 2 |
| Naranjo P. | 2 |
| Vega E. | 2 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats
ArticleAbstract: For vaccination against classical swine fever virus (CSFV), it is strongly desirable to induce a rapPalabras claves:CSFV, Duration of protection, E2 glycoprotein, Recombinant vaccinesAutores:Ávila M., Domínguez P., Farnos O., Frias M.T., Maritza Barrera, Rodriguez M.P., Sanchez O., Tait H., Toledo J.R., Vega E.Fuentes:scopusHuman αIFN co-formulated with milk derived E2-CSFV protein induce early full protection in vaccinated pigs
ArticleAbstract: Subunit vaccines are a suitable alternative for the control of classical swine fever. However, suchPalabras claves:E2-CSFV, Emergency vaccine, Human interferon, Subunit vaccineAutores:Aguero F., Farnos O., Gómez S., Maritza Barrera, Ormazabal V., Parra N.C., Rodriguez M.P., Sanchez O., Suárez L., Toledo J.R.Fuentes:scopusClassical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge
ArticleAbstract: E2 is the major envelope glycoprotein present on the outer surface of the classical swine fever viruPalabras claves:Adenovirus, classical swine fever, E2 glycoprotein, Protein production system, Veterinary vaccineAutores:Borroto C., Castell S., Farnos O., Figueroa N., Frias M.T., Ganges L., Maritza Barrera, Montesino R., Naranjo P., Rodriguez M.P., Sanchez O., Toledo J.R., Venereo A.Fuentes:scopusHighly protective E2-CSFV vaccine candidate produced in the mammary gland of adenoviral transduced goats
ArticleAbstract: Classical swine fever virus is the etiological agent of the most economically important highly contaPalabras claves:Adenoviral transduction, CSFV, E2 glycoprotein, Goat milk, Mammary gland, Veterinary vaccineAutores:Alfonso P., Cremata J.A., Farnos O., Frias M.T., Ganges L., Maritza Barrera, Montesino R., Oramas N., Rodríguez E., Rodriguez M.P., Sanchez O., Santana E., Toledo J.R., Vega E.Fuentes:scopusThermal stress treatment does not affect the stability and protective capacity of goat milk derived E2-marker vaccine formulation against CSFV
ArticleAbstract: Classical swine fever virus produces a huge mortality in infected herds during recurrent outbreaks,Palabras claves:E2-classical swine fever virus, Formulation stability, Mammary gland expression, Recombinant veterinary vaccineAutores:Aguero F., Aguilera A., Castell S., Farnos O., Figueredo J.M., Fonseca-Rodríguez O., Frias M.T., Maritza Barrera, Montesino R., Naranjo P., Prieto Y., Rodriguez M.P., Sanchez O., Toledo J.R.Fuentes:scopus